FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137267941> ?p ?o ?g. }

• W2137267941 endingPage "571" @default.
• W2137267941 startingPage "565" @default.
• W2137267941 abstract "Chronic hepatitis B (CHB) is a dynamic disease, therefore patients initially ineligible for treatment, based on current guidelines, often become eligible at some point during their follow-up evaluation. We investigated the reasons for this change and developed a timeline for treatment eligibility for this population.We performed a retrospective cohort study of 245 consecutive treatment-naive, community-based patients with CHB who were not eligible for treatment when they first presented, from March 2007 through June 2010 (mean age, 44 y, almost all Asian). The patients were followed up for a median period of 26 months, receiving standard laboratory tests. They were treated according to US panel 2008 and American Association for Liver Disease (AASLD) 2009 guidelines.Fifty-four patients (22%) became eligible for treatment during the follow-up period; most of these (n = 47; 87%) were based on only the US Panel algorithm and the rest were based on AASLD guidelines (n = 7; 13%). Six percent of patients met the treatment criteria at 1 year, 18% at 2 years, and 29% at 3 years. Among hepatitis B e antigen-positive patients with levels of hepatitis B virus (HBV) DNA greater than 3 log IU/mL at baseline, 11% met treatment criteria at 1 year, 52% at 2 years, and 80% at 3 years. Based on Cox multivariate analysis, which included age; sex; and levels of hepatitis B e antigen, alanine aminotransferase, and HBV DNA, an increase in HBV DNA level was the only factor from the US panel associated with treatment eligibility (hazard ratio, 1.43; P < .001), and an increase in alanine aminotransferase was the only factor associated with treatment eligibility from the AASLD guidelines (hazard ratio, 1.03; P = .001).Although most patients with CHB who initially are not eligible for treatment remain ineligible, almost 30% become eligible within 3 years. These findings indicate the importance of carefully following disease status in patients with CHB." @default.
• W2137267941 created "2016-06-24" @default.
• W2137267941 creator A5021543041 @default.
• W2137267941 creator A5023858668 @default.
• W2137267941 creator A5038740509 @default.
• W2137267941 creator A5055874431 @default.
• W2137267941 creator A5085003950 @default.
• W2137267941 date "2013-05-01" @default.
• W2137267941 modified "2023-10-02" @default.
• W2137267941 title "Treatment Eligibility of Patients With Chronic Hepatitis B Initially Ineligible for Therapy" @default.
• W2137267941 cites W1964619581 @default.
• W2137267941 cites W1966448677 @default.
• W2137267941 cites W1970492518 @default.
• W2137267941 cites W1982898260 @default.
• W2137267941 cites W2011946598 @default.
• W2137267941 cites W2031317669 @default.
• W2137267941 cites W2037314166 @default.
• W2137267941 cites W2039198180 @default.
• W2137267941 cites W2039210770 @default.
• W2137267941 cites W2049634632 @default.
• W2137267941 cites W2055205839 @default.
• W2137267941 cites W2059749879 @default.
• W2137267941 cites W2066720309 @default.
• W2137267941 cites W2068766858 @default.
• W2137267941 cites W2070769352 @default.
• W2137267941 cites W2071291950 @default.
• W2137267941 cites W2071805414 @default.
• W2137267941 cites W2072043368 @default.
• W2137267941 cites W2073754530 @default.
• W2137267941 cites W2087564721 @default.
• W2137267941 cites W2090388278 @default.
• W2137267941 cites W2097892923 @default.
• W2137267941 cites W2104389844 @default.
• W2137267941 cites W2115123213 @default.
• W2137267941 cites W2121314402 @default.
• W2137267941 cites W2131032734 @default.
• W2137267941 cites W2133195866 @default.
• W2137267941 cites W2135386419 @default.
• W2137267941 cites W2138576749 @default.
• W2137267941 cites W2142788779 @default.
• W2137267941 cites W2143216061 @default.
• W2137267941 cites W2156015715 @default.
• W2137267941 cites W2160554908 @default.
• W2137267941 cites W2165335004 @default.
• W2137267941 cites W2167596859 @default.
• W2137267941 cites W2170244859 @default.
• W2137267941 cites W4231124841 @default.
• W2137267941 cites W73738779 @default.
• W2137267941 doi "https://doi.org/10.1016/j.cgh.2012.12.028" @default.
• W2137267941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23333662" @default.
• W2137267941 hasPublicationYear "2013" @default.
• W2137267941 type Work @default.
• W2137267941 sameAs 2137267941 @default.
• W2137267941 citedByCount "17" @default.
• W2137267941 countsByYear W21372679412013 @default.
• W2137267941 countsByYear W21372679412014 @default.
• W2137267941 countsByYear W21372679412015 @default.
• W2137267941 countsByYear W21372679412016 @default.
• W2137267941 countsByYear W21372679412019 @default.
• W2137267941 countsByYear W21372679412020 @default.
• W2137267941 countsByYear W21372679412021 @default.
• W2137267941 countsByYear W21372679412022 @default.
• W2137267941 countsByYear W21372679412023 @default.
• W2137267941 crossrefType "journal-article" @default.
• W2137267941 hasAuthorship W2137267941A5021543041 @default.
• W2137267941 hasAuthorship W2137267941A5023858668 @default.
• W2137267941 hasAuthorship W2137267941A5038740509 @default.
• W2137267941 hasAuthorship W2137267941A5055874431 @default.
• W2137267941 hasAuthorship W2137267941A5085003950 @default.
• W2137267941 hasConcept C126322002 @default.
• W2137267941 hasConcept C167135981 @default.
• W2137267941 hasConcept C203014093 @default.
• W2137267941 hasConcept C207103383 @default.
• W2137267941 hasConcept C2522874641 @default.
• W2137267941 hasConcept C2777075537 @default.
• W2137267941 hasConcept C2777382497 @default.
• W2137267941 hasConcept C2780593183 @default.
• W2137267941 hasConcept C2908647359 @default.
• W2137267941 hasConcept C44249647 @default.
• W2137267941 hasConcept C50382708 @default.
• W2137267941 hasConcept C71924100 @default.
• W2137267941 hasConcept C90924648 @default.
• W2137267941 hasConcept C99454951 @default.
• W2137267941 hasConceptScore W2137267941C126322002 @default.
• W2137267941 hasConceptScore W2137267941C167135981 @default.
• W2137267941 hasConceptScore W2137267941C203014093 @default.
• W2137267941 hasConceptScore W2137267941C207103383 @default.
• W2137267941 hasConceptScore W2137267941C2522874641 @default.
• W2137267941 hasConceptScore W2137267941C2777075537 @default.
• W2137267941 hasConceptScore W2137267941C2777382497 @default.
• W2137267941 hasConceptScore W2137267941C2780593183 @default.
• W2137267941 hasConceptScore W2137267941C2908647359 @default.
• W2137267941 hasConceptScore W2137267941C44249647 @default.
• W2137267941 hasConceptScore W2137267941C50382708 @default.
• W2137267941 hasConceptScore W2137267941C71924100 @default.
• W2137267941 hasConceptScore W2137267941C90924648 @default.
• W2137267941 hasConceptScore W2137267941C99454951 @default.
• W2137267941 hasIssue "5" @default.

• next